Identification of Target Genes of Antiarrhythmic Traditional Chinese Medicine Wenxin Keli
Wenxin Keli (WXKL) is a traditional Chinese medicine drug approved for the treatment of cardiovascular diseases. This study aimed to identify WXKL-targeting genes involved in antiarrhythmic efficacy of WXKL. The Traditional Chinese Medicine Systems Pharmacology (TCMSP) technology platform was used t...
Saved in:
Main Authors: | Yusi Yao, Yuhong Liu, Zhihuan Zeng, Yanqun Zhao, Tudi Li, Rong Chen, Rendan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2020/3480276 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation
by: Nixiao Zhang, et al.
Published: (2018-01-01) -
Application of lipidomics in the study of traditional Chinese medicine
by: Yang Yang, et al.
Published: (2025-02-01) -
Tailoring traditional Chinese medicine in cancer therapy
by: Shuiquan Li, et al.
Published: (2025-01-01) -
Identification and Mass Spectrometric Fragmentation Pathways of Chemical Components in the Traditional Chinese Medicine Formula of Jiuwei Decoction
by: Jia-yu ZHAO, et al.
Published: (2025-01-01) -
The knowledge mapping of traditional Chinese medicine for hepatocellular carcinoma: A bibliometric study
by: Wenya Pei, et al.
Published: (2025-03-01)